| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c6a921f33fe0adc58c2b6177184515 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-61 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
1996-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_856e3e00ccce02c4e271a61e9f5a0874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d94f95a0f5ca3b24be76a4361a85768 |
| publicationDate |
1998-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5811074-A |
| titleOfInvention |
Method of diagnosing pituitary dependent growth hormone deficiency |
| abstract |
A diagnostic protocol and kit for evaluating pituitary growth hormone (GH) secretory capability as a means to identify the etiology of GH deficiency in children and adults is disclosed. The inventive protocol includes measuring GH secretion, provoked by independent, sequential administration of the xenobiotic GH releasing hexapeptide (GHRP-6) or any of its peptidyl or non-peptidyl synthetic analogues (GHRX) that release GH by the same cellular mechanism as GHRP-6 followed by the naturally occurring GH releasing hormone or its analogues (GHRH) to children and adults afflicted with disorders related to GH deficiency. After evaluating the effects of independent, sequential administration of the GH secretagogues upon changes in blood GH concentrations, the effect of the co-administered GH secretagogues on blood GH concentrations in the child or adult subject is then measured. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010135391-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6610496-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009305300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1120846-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8192719-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010135391-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007093820-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010297688-A1 |
| priorityDate |
1992-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |